Continue your surveillance as scheduled
However, patients experiencing significant weight loss on GLP-1 therapy may require more frequent monitoring, with TSH rechecked 6-8 weeks after significant weight change or dose adjustment, then every 3-4 months during active weight loss
[1] [2] Marketed under brand names including Ozempic, Wegovy, and Rybelsus, semaglutide works by mimicking the action of the naturally occurring hormone GLP-1, which enhances glucose-dependent insulin secretion, suppresses glucagon release, slows gastric emptying, and promotes satiety
Dehydration: Nausea reduces your desire to drink, and travel is inherently dehydrating particularly air travel
However, concurrent use should only occur under medical supervision with careful monitoring for additive side effects, particularly gastrointestinal symptoms
Instead, you should call your pharmacy or your doctor right away